Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
- PMID: 32229636
- DOI: 10.1212/WNL.0000000000009185
Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
Comment on
-
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.Neurology. 2019 Apr 30;92(18):e2070-e2080. doi: 10.1212/WNL.0000000000007232. Epub 2019 Apr 5. Neurology. 2019. PMID: 30952794 Free PMC article. Clinical Trial.
-
Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.Neurology. 2020 Mar 31;94(13):593-594. doi: 10.1212/WNL.0000000000009184. Neurology. 2020. PMID: 32229635 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical